研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

模仿林奇综合征的体质错配修复缺陷与低效错配修复基因变异相关。

Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants.

发表日期:2024 May 24
作者: Richard Gallon, Carlijn Brekelmans, Marie Martin, Vincent Bours, Esther Schamschula, Albert Amberger, Martine Muleris, Chrystelle Colas, Jeroen Dekervel, Gert De Hertogh, Jérôme Coupier, Orphal Colleye, Edith Sepulchre, John Burn, Hilde Brems, Eric Legius, Katharina Wimmer
来源: npj Precision Oncology

摘要:

林奇综合征 (LS) 和体质错配修复缺陷 (CMMRD) 是分别由单等位基因和双等位基因种系错配修复 (MMR) 变异引起的不同癌症综合征。 LS 在成年期主要易患胃肠道和泌尿生殖系统癌症。 CMMRD 从小就容易患脑癌、血液癌和 LS 谱癌症。两名年龄为 27 或 38 岁的首次癌症诊断疑似 LS 患者被发现为 MMR(可能)致病性变异 MSH6 c.3226C>T (p.(Arg1076Cys)) 或意义不确定的变异 (VUS) 纯合子, MLH1 c.306G>A (p.(Glu102=))。 MLH1 c.306G>A 显示会导致泄漏外显子 3 跳跃。通过检测两名患者的体质微卫星不稳定性(CMMRD 的标志性特征),解决了明显的基因型-表型冲突。通过文献综述发现,在其他晚发 CMMRD 病例中发现的这些变异和其他变异的亚效效应可能解释了 LS 样表型。对复合杂合子或纯合子 MMR VUS 携带者进行 CMMRD 检测可能会发现类似病例和新的亚等位变异。在我们更好地表征相关表型之前,需要对低等位 MMR 变异的单等位基因和双等位基因携带者进行个体化管理。© 2024。作者。
Lynch syndrome (LS) and constitutional mismatch repair deficiency (CMMRD) are distinct cancer syndromes caused, respectively, by mono- and bi-allelic germline mismatch repair (MMR) variants. LS predisposes to mainly gastrointestinal and genitourinary cancers in adulthood. CMMRD predisposes to brain, haematological, and LS-spectrum cancers from childhood. Two suspected LS patients with first cancer diagnosis aged 27 or 38 years were found to be homozygous for an MMR (likely) pathogenic variant, MSH6 c.3226C>T (p.(Arg1076Cys)), or variant of uncertain significance (VUS), MLH1 c.306G>A (p.(Glu102=)). MLH1 c.306G>A was shown to cause leaky exon 3 skipping. The apparent genotype-phenotype conflict was resolved by detection of constitutional microsatellite instability in both patients, a hallmark feature of CMMRD. A hypomorphic effect of these and other variants found in additional late onset CMMRD cases, identified by literature review, likely explains a LS-like phenotype. CMMRD testing in carriers of compound heterozygous or homozygous MMR VUS may find similar cases and novel hypomorphic variants. Individualised management of mono- and bi-allelic carriers of hypomorphic MMR variants is needed until we better characterise the associated phenotypes.© 2024. The Author(s).